Rita M Kramer

1.5k citations
18 papers · 1.2k · 1 hit paper · h-index 10

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Risks and Factors 4
    • HER2/EGFR in Cancer Research 2
    • Cancer survivorship and care 2
    • Breast Cancer Treatment Studies 3

Rita M Kramer

18 papers receiving 1.1k citations

Rita M Kramer's Hit Papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial 2017 · 461 citations
4610+3+6Years since publication100200300400

Peers

Rita M Kramer
Comparison fields: 5 of 77
  • Oncology 575
  • Cancer Research 192
  • Pulmonary and Respiratory Medicine 327
  • Endocrinology, Diabetes and Metabolism 145
  • Genetics 75
Replace Ritva Valavaara with:
Ritva Valavaara Finland
Seo Hee Choi South Korea
Jana Alexieva-Figusch Netherlands
Didier Meulendijks Netherlands
Mona El-Hashimy United States
Po‐Han Lin Taiwan
Reinhard Stege Sweden
Segundo Mariz Netherlands
Tanja Ignatov Germany
Manuel Ruiz-Echarri Spain
Rita M Kramer relative to Ritva Valavaara Finland Ritva Valavaara's profile →
Citations per field
00.5×5×10×15×20×23.3×
Ritva Valavaara · 1×
Citations per year

Countries citing papers authored by Rita M Kramer

Since Specialization
Citations

This map shows the geographic impact of Rita M Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita M Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita M Kramer more than expected).

Fields of papers citing papers by Rita M Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita M Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita M Kramer. The network helps show where Rita M Kramer may publish in the future.

Co-authors

The 25 scholars most cited alongside Rita M Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rita M Kramer Line = papers co-authored together Rita M Kramer links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017461
2 2006211
3 2000188
4 2007131
5 201566
6 201842
7 200920
8 201615
9
The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.
200612
10 200411
11 20049
12 20106
13 20206
14 20045
15
Representative breast size of reference female
19814
16 20182
17 19791
18
Maria Montessori : Leben und Werk einer großen Frau
19761

About Rita M Kramer

Rita M Kramer is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Genetics and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Risks and Factors (4 papers), Estrogen and related hormone effects (3 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers), Historical Education Studies Worldwide (2 papers), Menopause: Health Impacts and Treatments (2 papers), Education Methods and Practices (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Oncology (575 citations), Cancer Research (192 citations), Pulmonary and Respiratory Medicine (327 citations), Endocrinology, Diabetes and Metabolism (145 citations) and Genetics (75 citations). Rita M Kramer has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Richard M. Elledge, Krystal R. Sexton, Susan Galloway Hilsenbeck, Lois C. Friedman, Heidi L. Weiss, Claudine J. Isaacs, Vered Stearns, Daniel F.C. Hayes, Julia Howe Rowland and Jeffrey Crawford. Their work appears in journals such as Advances in cancer research, Breast Cancer Research and Treatment, The FASEB Journal, Frontiers in Oncology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact